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COL4A1 mutations have been associated with a variety of
vascular abnormalities and disease manifestations, including
porencephaly, infantile hemiparesis, intracerebral hemorrhage in
neonates and children, intracerebral hemorrhage and cerebral
small vessel disease in adulthood, intracranial aneurysms, and
retinal arteriolar tortuosities [1]. The gene encodes for type IV
collagen a1 that forms the vascular basement membrane in
heterotrimer triple helix collagen. Seizures have been described
with COL4A1 mutation, the reasons for which are unknown. We
present a patient with COL4A1 mutation who developed status
epilepticus, and offer a hypothesis generating explanation for
seizures in this monogenic cerebral small vessel disease.
2. Case report
A 61-year old woman was admitted to our hospital for
management of ongoing seizures. Her past medical history
included hypertension, hyperlipidemia, depression and chronic
kidney disease. Her neurologic history included migraine with
visual aura, recurrent ischemic stroke and transient ischemic
attacks starting at age 26, and recurrent intracerebral hemorrhage
starting at age 59. She was of European-American descent without
family history of cerebrovascular disease. Diagnostic evaluation
revealed severe diffuse cerebral leukoencephalopathy, multiple
subcortical lacunar infarcts and subcortical micro-hemorrhages on
magnetic resonance imaging (MRI) (Fig. 1). The ﬁrst available MRI
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the interval time period showed marked accumulation of
subcortical lacunar infarcts and micro-hemorrhages. The micro-
hemorrhages were numerous and were in a distribution that
closely paralleled the white matter hyperintensities. There was no
suggestion of cognitive or neuromuscular involvement. Given the
clinic-radiologic presentation, genetic testing for Cerebral autoso-
mal dominant arteriopathy with subcortical infarcts and leukoen-
cephalopathy (CADASIL) was performed but was negative.
Additional evaluation included ophthalmologic testing that
revealed normal retinal vasculature. Review of records revealed
evidence of stage III chronic kidney disease for approximately 10-
years prior to initial evaluation (baseline creatinine 1.4 mg/dl)
with an atrophic left kidney, and a normal sized right kidney with a
cyst. There was no evidence of calciﬁcation on renal arteries to
suggest advanced atherosclerosis or renal artery stenosis on
abdominal computed tomography (CT) scanning. Urine analysis
was positive for 1+ microscopic hematuria. Based on the
constellation of systemic ﬁndings, she was tested and found
positive for the COL4A1 mutation (c.2086G>A;p.Gly696Ser) one
year prior to admission. Genetic testing and counseling was offered
to family members. She had one daughter who was deceased from
‘‘cancer’’. Here parents were also deceased and one living biological
brother was unavailable for testing.
This hospitalization was prompted when she developed acute
onset of right arm tonic posturing and right gaze preference,
followed by a generalized tonic clonic seizure lasting 30 min. She
was intubated at an outside emergency room, administered anti-
epileptics including intravenous lorazepam, phenobarbital and
fosphenytoin sodium, and subsequently admitted to the neuro-
logical intensive care unit. Initial evaluation included CT of the
head that was unremarkable for an acute process. Continuous
electroencephalographic monitoring revealed bilateral periodic
lateralized epileptiform discharges (BIPLEDs) on a background of
generalized, continuous slow waves (Fig. 1). Subsequent work up
included an MRI of the brain, which did not reveal any acute infarct
but showed stable, extensive T2/FLAIR leukoencephalopathy and
extensive susceptibility artifact on susceptibility-weighted imag-
ing. There was increased T2/FLAIR signal in the left hippocampal
body without gadolinium enhancement (Fig. 1), which was
thought to represent transient postictal hippocampal edema given
the location and its reversibility on follow up MRI. A lumbar
puncture was performed and cerebrospinal ﬂuid analysis revealedserved.
Fig. 1. Axial susceptibility weighted images (Panel A) showing numerous micro-hemorrhages in the subcortical white matter, along with diffuse white matter hyperintensity
and numerous lacunar infarcts on axial FLAIR images (Panel B). A 10 s epoch of the electroencephalogram (Panel C) showing bi-hemispheric, high ampliude, sharp waves that
are asynchronous, representative of BIPLEDs.
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12% monocytes and 1% eosinophils. Protein and glucose levels
were 38 and 71 mg/dl respectively. Herpes Simplex Virus detection
by polymerase chain reaction testing was negative.
She was treated for status epilepticus with fosphenytoin
sodium, levetiracetam, lacosamide and midazolam intravenous
infusions. She initially continued to have right lateralizing seizures
arising from a background of burst suppression. Thereafter,
BIPLEDs persisted along with runs of a periodic pattern in the
bifrontal lobes without evidence of seizures. We did not have anearlier electroencephalogram for comparison since she did not
have a history of seizures, and an electroencephalogram was never
performed prior to this admission. She underwent a tracheostomy
18 days after admission, and was discharged to a long-term acute
care facility a month after admission.
3. Discussion
We present a patient with COL4A1 mutation who presented
with new onset seizure and status epilepticus with prior ischemic
S. John et al. / Seizure 31 (2015) 19–21 21and hemorrhagic brain lesions. The c.2086G>A;p.Gly696Ser is a
novel DNA sequence variant with no known published research on
it. Although this variant is of unknown clinical signiﬁcance, both
SIFT (Sorting Intolerant From Tolerant) and PolyPhen-2.2.2
programs predicted that this variant is more likely pathogenic
than benign. This patient had typical clinical and imaging
phenotype of COL4A1 mutation including leukoencephalopathy,
subcortical lacunar infarcts, and subcortical micro-hemorrhages.
As such, it could be argued that the seizures were likely secondary
to accumulation of structural brain lesions. However, the presence
of persistent BIPLEDs in the absence of acute or chronic cortical
lesions, infection or metabolic disturbances suggests that the
seizures cannot be explained entirely by local structural changes
alone, but may represent a more diffuse electrophysiological
process. We hypothesize that COL4A1 disease manifestations may
not be solely secondary to vascular compromise, but may have an
electrophysiological substrate. Although conjectural, this may be
secondary to yet undiscovered altered neurotransmission in the
cerebral cortex that causes decreasing inhibition and/or increasing
excitatory neurotransmission. This results in convergence of
disparate oscillations by coupling, until there is emergence of
one dominant oscillation.
COL4A1 mutation causes a systemic vascular basement
membrane disease. Its manifestations are widespread and variable,
involving the brain, eye and kidneys [1]. Similar to COL4A1
mutation, CADASIL is a monogeneic cause of cerebral small vessel
disease caused by a mutation in the Notch3 gene. An interesting
feature of CADASIL is that patients experience migraine with aura
at ﬁve times the frequency of the general population [2]. This is
also the ﬁrst clinical manifestation, which may occur in the
absence of neuroimaging abnormalities. Studies on transgenic
mice that develop age-dependent Notch3 ECD and GOM deposits
without brain lesions demonstrated that they have much lower
threshold for cortical spreading depression as well as a higher
speed of propagation [3]. This susceptibility was unchanged in a
mouse model of chronic forebrain hypoperfusion arguing against
the involvement of hypoperfusion.
Epileptic seizures have been described with COL4A1 mutation
[4]. Akin to migraine in CADASIL, COL4A1 mutations may lead to
disturbances in normal cortical electrophysiologic function result-
ing in a pathologically low threshold for activation of cortical
hyperexitability.4. Conclusion
This report is hypothesis generating. Seizures are part of the
clinical spectrum of COL4A1 mutation, and may be related to
electrophysiological processes altering the threshold potentials for
seizure generation.
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